alexa COVID-19 in a Patient with Visceral Leishmaniasis | OMICS International | Abstract
ISSN: 2332-0877

Journal of Infectious Diseases & Therapy
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

COVID-19 in a Patient with Visceral Leishmaniasis

Antonio Marco Miotti*, Aria Patacca, Carmela Grosso and Francesco Cristini
Operative Unit of Infectious Diseases, Hospitals of Forlì and Cesena-AUSL, Romagna, Italy
*Corresponding Author: Antonio Marco Miotti, Unità Operativa di Malattie Infettive, Ospedali di Forlì e Cesena - AUSL Romagna, Italy, Email: [email protected]

Received Date: Jun 25, 2020 / Accepted Date: Jul 10, 2020 / Published Date: Jul 17, 2020

Citation: Miotti AM, Patacca A , Grosso C, Cristini F (2020) COVID-19 in a Patient with Visceral Leishmaniasis. J Infect Dis Ther 8: 430.

Copyright: © 2020 Miotti AM, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

To read the full article Peer-reviewed Article PDF image


Visceral Leishmaniasis is an infectious disease caused by protozoans of Leishmania genus and transmitted by the bite of infected sand flies. Its course is fatal in the absence of appropriate treatment.

Coronavirus disease 2019 (COVID-19) is a respiratory tract infection, first detected in Wuhan, China, in December 2019 and subsequently spread worldwide as a pandemic. It is caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). In its most severe forms, it proves to be life threatening.

Hereby we report, to the best of our knowledge, the first case of COVID-19 in a patient with Visceral Leishmaniasis. He was a 79-year-old Italian male seeking medical attention because of sub-chronic fever associated with asthenia, lack of appetite, weight loss and pancytopenia. After a series of routine tests, the man underwent a bone marrow biopsy, which led to the diagnosis of Visceral Leishmaniasis. He was thus given liposomal amphotericin B, with moderate improvement of clinical conditions and laboratory exams. However, the hospital stay was complicated by COVID-19, since the patient tested positive for SARS-CoV-2 and developed severe interstitial pneumonia, thrombosis of the pulmonary vessels and possible alevolar hemorrhage. Due to multiple comorbidities, the options for Coronavirus treatment were extremely limited and death followed.